Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 17095 participants.
Also called NCT05183178
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 17,095 participants
- Registry
-
NCT05183178
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Sweden
- Registry status
- Completed
Technical summary
Registry record NCT05183178. Randomized; no masking; primary purpose treatment. Start 2022-02-01 (actual); primary completion 2025-08-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
- Acronym
- SWITCH
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Prasugrel 10 mg p.o
- Intervention (Drug)
- Ticagrelor 90 mg
- Lead sponsor
- Vastra Gotaland Region
- Collaborator
- Region Skane
- Collaborator
- Region Halland
- Collaborator
- Region Gävleborg
- Collaborator
- Region Örebro County
- Collaborator
- Region Västerbotten
- Collaborator
- Jämtland County Council, Sweden
Record details
- Record id
cardio:ct-nct05183178- Content hash
b5d8babc1f7528cac4ff7307d4846446adfa2a7f7df150fb44de8fc68ffd9ad3